{"title":"Binding uric acid: a pure chemical solution for the treatment of hyperuricemia","link":"http://pubs.rsc.org/en/Content/ArticleLanding/2024/RA/D4RA04626A","date":null,"content":"<div><p><img src=\"/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D4RA04626A\" /></p></div><div><i><b>RSC Adv.</b></i>, 2024, <b>14</b>,24165-24174<br /><b>DOI</b>: 10.1039/D4RA04626A, Paper</div><div><img alt=\"Open Access\" src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png\" /> Open Access</div><div><a href=\"http://creativecommons.org/licenses/by-nc/3.0/\" target=\"_blank\"> <img src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY-NC.png\" alt=\"Creative Commons Licence\" /></a>Â  This article is licensed under a <a href=\"http://creativecommons.org/licenses/by-nc/3.0/\" target=\"_blank\">Creative Commons Attribution-NonCommercial 3.0 Unported Licence.</a></div><div>Yun-Yun Li, Jing Li, Yan Li, Hong-Ping Long, Wei Lin, Yi-Kun Wang, Rong Tang, Xue-Wu Liu, Dejian Jiang, Shao Liu, Dongsheng Cao, Gui-Shan Tan, Kang-Ping Xu, Wen-Xuan Wang<br />A binding partner designed for uric acid inhibits its precipitation and ionization, and shows an anti-hyperuricemia activity <em>in vivo</em> competitive with benzbromarone, as well as a favorable safety profile.<br />The content of this RSS Feed (c) The Royal Society of Chemistry</div>","author":"","siteTitle":"RSC - RSC Adv. latest articles","siteHash":"da3e282678330308414c63a405ade89dd3738fcce2936ca8a2fe3a6d7e967d99","entryHash":"efb2ee5f31f36efe0bcc9df86f965e15fd33613318edf3f1d655684d37d186ca","category":"Environment"}